A new classification framework introduces structured phenotyping to guide hormonal therapy in male infertility, addressing long-standing reliance on empirical treatment approaches.

Monthly subs available through telehealth services will help Novo solidify its orals lead in advance of Lilly’s expected entry into the category.

HPV, a common virus, poses a silent threat to family health, leading to cancers like cervical cancer. Experts urge ...

In collaboration with researchers in South Korea, a team from The Hospital for Sick Children (SickKids) has discovered a ...

About 75% of pregnant patients at risk for preeclampsia are not taking low-dose aspirin, the recommended preventive treatment, according to research presented at the American College of Cardiology ...

The FDA approves Apotex Corp.'s plan to introduce generic Ozempic, a semaglutide injection that one study suggests could ...

The U.S. Food and Drug Administration announced on Thursday its approval of a new, higher-dose Wegovy (semaglutide) injection. The 7.2 mg dosage, called Wegovy HD, is intended for weight loss and long ...

Full-body cancer screening can aid early detection, but it has limits. Here’s what it finds, what it misses, and why ...

Ivermectin tablets are dosed based on body weight and the specific parasitic infection treated. Strongyloidiasis requires approximately 200 micrograms per kilogram of body weight (mcg/kg) and ...

The FDA approved a once-daily oral GLP-1 receptor agonist for adults with obesity or overweight with weight-related ...

MiraLAX is an over-the-counter (OTC) laxative powder containing polyethylene glycol 3350 for use to relieve constipation. It is intended for adults and children ages 17 years and older. The ...